Caricamento...
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
BACKGROUND: Healthcare decisions made on the basis of insufficient evidence may potentially have ineffective or even harmful consequences. The proportion of older ages (over 65 years) in randomized controlled trials (RCTs) for severe asthma is not enough to establish whether anti-IL-5/IL-5R therapie...
Salvato in:
| Pubblicato in: | World Allergy Organ J |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
World Allergy Organization
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6931205/ https://ncbi.nlm.nih.gov/pubmed/31890084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2019.100081 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|